Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Preliminary findings suggest that positron emission tomography/CT (PET/CT), using the radiotracer fluoro-L-thymidine (FLT), might be able to quickly show whether chemotherapy is working in patients with acute myelogenous leukemia (AML).

AML patients: New way to gauge treatment response